These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23601015)

  • 1. Recurrent cerebrospinal fluid shunt infection and the efficacy of reusing infected ventricular entry sites.
    Winston KR; Ho JT; Dolan SA
    J Neurosurg Pediatr; 2013 Jun; 11(6):635-42. PubMed ID: 23601015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reuse of ventricular drain sites for cerebrospinal fluid shunting in patients with no prior infection.
    Winston KR; Bhardwaj V
    J Neurosurg Pediatr; 2010 May; 5(5):449-53. PubMed ID: 20433255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts.
    Parker SL; Attenello FJ; Sciubba DM; Garces-Ambrossi GL; Ahn E; Weingart J; Carson B; Jallo GI
    Childs Nerv Syst; 2009 Jan; 25(1):77-83; discussion 85. PubMed ID: 18985357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an institutional guideline for the treatment of cerebrospinal fluid shunt-associated infections.
    von der Brelie C; Simon A; Gröner A; Molitor E; Simon M
    Acta Neurochir (Wien); 2012 Sep; 154(9):1691-7. PubMed ID: 22454037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shunt infection: is there a near-miss scenario?
    Thompson DN; Hartley JC; Hayward RD
    J Neurosurg; 2007 Jan; 106(1 Suppl):15-9. PubMed ID: 17233307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
    Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
    BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antibiotic-impregnated shunts on infection rate in adult hydrocephalus: a single institution's experience.
    Farber SH; Parker SL; Adogwa O; McGirt MJ; Rigamonti D
    Neurosurgery; 2011 Sep; 69(3):625-9; discussion 629. PubMed ID: 21499157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origin of organisms infecting ventricular shunts.
    Shapiro S; Boaz J; Kleiman M; Kalsbeck J; Mealey J
    Neurosurgery; 1988 May; 22(5):868-72. PubMed ID: 3380276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative management of patients with cerebrospinal fluid shunt infections.
    Brown EM; Edwards RJ; Pople IK
    Neurosurgery; 2006 Apr; 58(4):657-65; discussion 657-65. PubMed ID: 16575329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections.
    Arnell K; Enblad P; Wester T; Sjölin J
    J Neurosurg; 2007 Sep; 107(3 Suppl):213-9. PubMed ID: 17918527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of shunt infections: a multicenter pilot study.
    Kestle JR; Garton HJ; Whitehead WE; Drake JM; Kulkarni AV; Cochrane DD; Muszynski C; Walker ML
    J Neurosurg; 2006 Sep; 105(3 Suppl):177-81. PubMed ID: 16970229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters.
    Attenello FJ; Garces-Ambrossi GL; Zaidi HA; Sciubba DM; Jallo GI
    Neurosurgery; 2010 Feb; 66(2):284-9; discussion 289. PubMed ID: 20087127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid shunt infection: a prospective study of risk factors.
    Kulkarni AV; Drake JM; Lamberti-Pasculli M
    J Neurosurg; 2001 Feb; 94(2):195-201. PubMed ID: 11213954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus.
    Govender ST; Nathoo N; van Dellen JR
    J Neurosurg; 2003 Nov; 99(5):831-9. PubMed ID: 14609161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of causative organism and time to infection among children with cerebrospinal fluid shunt infection.
    Test MR; Whitlock KB; Langley M; Riva-Cambrin J; Kestle JRW; Simon TD
    J Neurosurg Pediatr; 2019 Jul; 24(1):22-28. PubMed ID: 31051463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endoscopic third ventriculostomy at infected cerebrospinal fluid shunt removal.
    Shimizu T; Luciano MG; Fukuhara T
    J Neurosurg Pediatr; 2012 Mar; 9(3):320-6. PubMed ID: 22380962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat cerebrospinal fluid shunt infection in children.
    Kulkarni AV; Rabin D; Lamberti-Pasculli M; Drake JM
    Pediatr Neurosurg; 2001 Aug; 35(2):66-71. PubMed ID: 11549916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive management of shunt infection: combined intravenous and intraventricular antibiotic therapy for twelve or less days.
    James HE; Bradley JS
    Pediatr Neurosurg; 2008; 44(2):104-11. PubMed ID: 18230923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens.
    McGirt MJ; Zaas A; Fuchs HE; George TM; Kaye K; Sexton DJ
    Clin Infect Dis; 2003 Apr; 36(7):858-62. PubMed ID: 12652386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters.
    Eymann R; Chehab S; Strowitzki M; Steudel WI; Kiefer M
    J Neurosurg Pediatr; 2008 Jun; 1(6):444-50. PubMed ID: 18518694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.